New content highlighted for Cancer


  • Raphael E. Pollock MD, PhD

    Corresponding author
    1. Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030
    Search for more papers by this author
    • Fax: (713) 794-0722

As the journal Cancer continues in its quest to provide content of increased breadth and depth to our readership, I would like to call your attention to several additions that we hope you will find useful. In light of the increasing volume of submissions and the emerging importance of the oncology disciplines of Disparities Research and Outcomes Research, we have chosen to elevate these 2 fields by according them permanent section status in the editorial content of Cancer. I am delighted that Lisa Newman, MD, of the University of Michigan Medical Center and Smita Bhatia, MD, MPH, of the City of Hope Cancer Center have agreed to become our Section Editors for these 2 disciplines, respectively. In an additional transition, Dr. Vernon Sondak is stepping down as Section Editor for Melanoma. Vern's years of service to Cancer are noted and deeply appreciated. Although Dr. Sondak will be sorely missed, I am happy to report that Kim Margolin, MD, FACP, of the City of Hope Cancer Center has accepted our offer to become the new Melanoma Section Editor.

I would also like to call your attention to a new additional section that we are creating. Dr. James Cusack of the Massachusetts General Hospital has kindly agreed to become a Section Editor for a new Cancer endeavor that will focus on review reports of relevant translational research developments as they apply to the practice of oncology. I am confident that Jim will bring a vigorous clinical as well as research perspective to this new effort.

Finally, we are also launching a new section in Cancer entitled “CancerScope.” CancerScope will seek to address timely social, economic, and rapidly developing research issues that materially impact on cancer care as well as other concerns relevant to the cancer patient, and will be led by Carrie Printz, MD.

Please join me in welcoming Lisa, Smita, Kim, Jim, and Carrie. I hope that you enjoy these new efforts. It is our hope to make Cancer the most useful and relevant journal possible, and I would very much welcome your thoughts on these changes!